Annual Research Review: New frontiers in developmental neuropharmacology: can long‐term therapeutic effects of drugs be optimized through carefully timed early intervention?
Open accessThe DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Our aim is to present a working model that may serve as a valuable heuristic to predict enduring effects of drugs when administered during development. Our primary tenet is that a greater understanding of neurodevelopment can lead to improved treatment that intervenes early in the progression of a given disorder and prevents symptoms from manifesting. The immature brain undergoes significant changes during the transitions between childhood, adolescence, and adulthood. Such changes in innervation, neurotransmitter levels, and their respective signaling mechanisms have profound and observable changes on typical behavior, but also increase vulnerability to psychiatric disorders when the maturational process goes awry. Given the remarkable plasticity of the immature brain to adapt to its external milieu, preventive interventions may be possible. We intend for this review to initiate a discussion of how currently used psychotropic agents can influence brain development. Drug exposure during sensitive periods may have beneficial long‐term effects, but harmful delayed consequences may be possible as well. Regardless of the outcome, this information needs to be used to improve or develop alternative approaches for the treatment of childhood disorders. With this framework in mind, we present what is known about the effects of stimulants, antidepressants, and antipsychotics on brain maturation (including animal studies that use more clinically‐relevant dosing paradigms or relevant animal models). We endeavor to provocatively set the stage for altering treatment approaches for improving mental health in non‐adult populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00017-8 · Cited by 18,943
Why do many psychiatric disorders emerge during adolescence?
Paus, T., Keshavan, M., & Giedd, J. N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2513 · Cited by 3,123 · cited 3×
“…modern day structural imaging studies further show changes in gray and white matter across key maturational periods of childhood and adolescence (Giedd et al., 1999, Giedd et al., 1996a, Giedd et al., 1996b, Sowell et al., 2001, Sowell et al., 2004, Tau and Peterson, 2010, Paus et al., 2008).”
Nature-nurture reconceptualized in developmental perspective: A bioecological model.
Bronfenbrenner, U., & Ceci, S. J. (1994) · Psychological Review · doi:10.1037/0033-295x.101.4.568 · Cited by 2,973
Excitatory actions of gaba during development: the nature of the nurture
Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448 · cited 1×
“Within this framework, complex neural networks exist that are sculpted by both spontaneous and experience-driven activity with changes that are unique to specific windows of development (Katz and Shatz, 1996, Zhang and Poo, 2001, Ben-Ari, 2002, Francis et al., 2002).”
Hankin, B. L., Abramson, L. Y., Moffitt, T. E., Silva, P. A., McGee, R., & Angell, K. E. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.1.128 · Cited by 2,333 · cited 1×
“Targeting at-risk populations, when the greatest surge in the number of newly emergent cases occurs between 15–18 years (Hankin et al., 1998), would greatly reduce adult prevalence rates.”
Critical period plasticity in local cortical circuits
Hensch, T. K. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1787 · Cited by 2,323 · cited 4×
“Reduced neurotrophic factors signal the closing of a sensitive period (as described in the visual system; Hensch, 2005).”
InfluentialSynaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070 · cited 2×
“PVB GABA neurons are fast-spiking interneurons that modulate neuronal activity (Bartos et al., 2007), and changes (typically reductions) have been found in post-mortem studies of schizophrenia, bipolar disorder, and depression (Benes, 2009, Lewis et al., 1999).”
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980 · cited 1×
“Similarly, humans with the s-type 5-HTTLPR polymorphism, which functionally elevates 5- HT levels, have increased amygdala activity to fearful faces that is further associated with reduced PFC volume (Pezawas et al., 2005, Munafo et al., 2008).”
Edwards, V. J., Holden, G. W., Felitti, V. J., & Anda, R. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1453 · Cited by 1,832
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., & Rapoport, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707741104 · Cited by 1,819
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 2×
“Pharmacogenomics This rapidly evolving field may identify new targets, including four genes affected by antidepressants in adult animals (Crowley et al., 2006, Heurteaux et al., 2006, Svenningsson and Greengard, 2007, Tsankova et al., 2006).”
Sesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902900205 · Cited by 1,568
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“In adults, chronic drug administration is accompanied by compensatory changes in structure and function (Creese et al., 1977, Nestler and Aghajanian, 1997, Brunello et al., 2002, Cryan et al., 2002).”
Differential projections of the infralimbic and prelimbic cortex in the rat
Vertes, R. P. (2004) · Synapse · doi:10.1002/syn.10279 · Cited by 1,550
Structural and functional brain development and its relation to cognitive development
Casey, B. J., Giedd, J. N., & Thomas, K. M. (2000) · Biological Psychology · doi:10.1016/s0301-0511(00)00058-2 · Cited by 1,506
Trajectories of brain development: point of vulnerability or window of opportunity?
Andersen, S. L. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00005-8 · Cited by 1,503 · cited 8×
“…system differences With continued refinement in our level of analysis, synaptic changes occurring at differing rates within individual neurotransmitter systems have been demonstrated, including innervation patterns, neurotransmitter levels, and signaling mechanisms (Andersen, 2003).”
InfluentialSelf-citationNormal development of brain circuits
Tau, G. Z., & Peterson, B. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.115 · Cited by 1,391
Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript behavioral therapy or community clinical care (Molina et al., 2009, Reinecke et al., 2009, Vaughan et al., 2008).”
Characterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170 · cited 1×
“While ADHD has been conceptualized primarily as an executive dysfunction disorder (Barkley, 1997), our recent understanding of ADHD pathology has broadened to include dysfunction in reward-related domains (Sonuga-Barke, 2003, Castellanos et al., 2006).”
Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder
Dawson, G. (2008) · Development and Psychopathology · doi:10.1017/s0954579408000370 · Cited by 1,138 · cited 1×
“For example, early behavioral interventions can have a positive effect in ameliorating behavioral problems and improving psychosocial functioning of children with autism (Dawson, 2008).”
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · cited 1×
“Atomoxetine affects norepinephrine neurotransmission primarily, but also dopamine in the PFC (Bymaster et al., 2002).”
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · cited 1×
“Agents that reduce glutamate actions, such as NMDA antagonists or a NR2b receptor antagonist, may provide some benefit under conditions in which depression is related to increased basolateral amygdala activity (Maeng et al., 2008).”
Spatz Widom, C., DuMont, K., & Czaja, S. J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.49 · Cited by 1,059 · cited 1×
“Second, exposure to childhood sexual abuse is associated with the first episodes of depression occurring between 12–15 years of age (Teicher et al., 2009, Widom et al., 2007).”
Quantitative magnetic resonance imaging of human brain development: ages 4–18
Giedd, J. N., Snell, J. W., Lange, N., Rajapakse, J. C., Casey, B. J., Kozuch, P. L., Vaituzis, A. C., Vauss, Y. C., Hamburger, S. D., Kaysen, D., et al. (1996) · Cerebral Cortex · doi:10.1093/cercor/6.4.551 · Cited by 1,024 · cited 1×
“…modern day structural imaging studies further show changes in gray and white matter across key maturational periods of childhood and adolescence (Giedd et al., 1999, Giedd et al., 1996a, Giedd et al., 1996b, Sowell et al., 2001, Sowell et al., 2004, Tau and Peterson, 2010, Paus et al., 2008).”
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013 · cited 1×
“In addition, reduction of D1 receptors on glutamate neurons may also improve executive function deficits by reducing “noise” from other inputs (Vijayraghavan et al., 2007, Russell et al., 2005).”
Stress, sensitive periods and maturational events in adolescent depression
Andersen, S. L., & Teicher, M. H. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.01.004 · Cited by 1,005
Self-citationBecker, J. B., & Hu, M. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.07.003 · Cited by 1,003 · cited 1×
“Estrogenic effects on catecholamine transporters (Becker and Hu, 2008) should enhance drug action in cycling females, but the effects on α2a signaling are unknown.”
SÁNCHEZ, M. M., LADD, C. O., & PLOTSKY, P. M. (2001) · Development and Psychopathology · doi:10.1017/s0954579401003029 · Cited by 1,003
Sowell, E. R., Thompson, P. M., Tessner, K. D., & Toga, A. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08819.2001 · Cited by 983 · cited 1×
“…modern day structural imaging studies further show changes in gray and white matter across key maturational periods of childhood and adolescence (Giedd et al., 1999, Giedd et al., 1996a, Giedd et al., 1996b, Sowell et al., 2001, Sowell et al., 2004, Tau and Peterson, 2010, Paus et al., 2008).”
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
Heidbreder, C. A., & Groenewegen, H. J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.09.003 · Cited by 882
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845 · cited 1×
“Functionally, acute MPH increases cerebral blood metabolism and flow in humans (Kim et al., 2001, Vaidya et al., 1998), and preclinical data suggests that repeated MPH exposure in juvenile rats permanently increases relative cerebral blood flow in response to drug challenge (Andersen et al., 2008a).”
Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Ansorge, M. S., Zhou, M., Lira, A., Hen, R., & Gingrich, J. A. (2004) · Science · doi:10.1126/science.1101678 · Cited by 817 · cited 4×
“For example, elevated 5-HT activity during early development (e.g., 9–16 days of age in the rat) increases anxiety and depression in rats and mice later in life (Feng et al., 2001, Gross et al., 2002, Andersen et al., 2002a, Ansorge et al., 2004).”
InfluentialThe dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics
Sonuga-Barke, E. J. S. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.005 · Cited by 816 · cited 2×
“…subjects are less sensitive to changes in reinforcement contingencies (Murray and Kollins, 2000), prefer smaller rewards sooner over larger rewards later (a measure of impulsivity known as delay aversion; Sonuga-Barke, 2003), and are insensitive to punishment and partial reinforcement (Quay, 1997).”
Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis
Munafò, M. R., Brown, S. M., & Hariri, A. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.016 · Cited by 789 · cited 1×
“Similarly, humans with the s-type 5-HTTLPR polymorphism, which functionally elevates 5- HT levels, have increased amygdala activity to fearful faces that is further associated with reduced PFC volume (Pezawas et al., 2005, Munafo et al., 2008).”
Andersen, S. L., Tomada, A., Vincow, E. S., Valente, E., Polcari, A., & Teicher, M. H. (2008) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2008.20.3.292 · Cited by 788 · cited 6×
“Exposure to environmental information/stimulation can positively or negatively shape brain development as well as have maximal impact during certain periods of maturation (Sonuga-Barke, 2010, Sanchez et al., 2001, Andersen and Navalta, 2004, Andersen et al., 2008).”
InfluentialSelf-citationPerineuronal Nets Protect Fear Memories from Erasure
Gogolla, N., Caroni, P., Lüthi, A., & Herry, C. (2009) · Science · doi:10.1126/science.1174146 · Cited by 760 · cited 1×
“By manipulating CSPGs, Gogolla and colleagues (Gogolla et al., 2009) were able to enhance extinction to fear stimuli that recapitulates an earlier state of development when juvenile animals show rapid extinction.”
Beesdo, K., Bittner, A., Pine, D. S., Stein, M. B., Höfler, M., Lieb, R., & Wittchen, H.-U. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.903 · Cited by 731 · cited 4×
“Furthermore, given that 62% of pediatric cases of generalized anxiety disorder convert to depression in adolescence (Beesdo et al., 2007), reducing glutamate may serve as an effective prevention of symptoms.”
InfluentialTriadic model of the neurobiology of motivated behavior in adolescence.
ERNST, M., PINE, D. S., & HARDIN, M. (2006) · Psychological Medicine · doi:10.1017/s0033291705005891 · Cited by 718 · cited 1×
“Noveltyseeking is another important characteristic of ADHD that may reflect a greater need for rewarding stimulation (Ernst et al., 2006).”
Inhibitory threshold for critical-period activation in primary visual cortex
Fagiolini, M., & Hensch, T. K. (2000) · Nature · doi:10.1038/35004582 · Cited by 716
Environmental Enrichment Reverses the Effects of Maternal Separation on Stress Reactivity
Francis, D. D., Diorio, J., Plotsky, P. M., & Meaney, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07840.2002 · Cited by 663
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission
Kalivas, P. W., Volkow, N., & Seamans, J. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.005 · Cited by 657
Behavioral and Neural Consequences of Prenatal Exposure to Nicotine
ERNST, M., MOOLCHAN, E. T., & ROBINSON, M. L. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00007 · Cited by 590
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · cited 1×
“While ADHD has been conceptualized primarily as an executive dysfunction disorder (Barkley, 1997), our recent understanding of ADHD pathology has broadened to include dysfunction in reward-related domains (Sonuga-Barke, 2003, Castellanos et al., 2006).”
Mapping Changes in the Human Cortex throughout the Span of Life
Sowell, E. R., Thompson, P. M., & Toga, A. W. (2004) · The Neuroscientist · doi:10.1177/1073858404263960 · Cited by 572 · cited 2×
“From this perspective, longitudinal studies will be helpful in determining the sequence of regional brain changes as different cascades of events unfold (Gogtay et al., 2006, Sowell et al., 2004).”
Prefrontal cortical-amygdalar metabolism in major depression.
DREVETS, W. C. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09292.x · Cited by 557
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Development of the dopaminergic innervation in the prefrontal cortex of the rat
Kalsbeek, A., Voorn, P., Buijs, R. M., Pool, C. W., & Uylings, H. B. M. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902690105 · Cited by 545 · cited 1×
“Ectopic expression is best characterized for the monoamines: dopamine (Gelbard et al., 1990, Todd, 1992, Lankford et al., 1988, Kalsbeek et al., 1988), norepinephrine (Feeney and Westerberg, 1990, Kline et al., 1994), and 5-HT (Lauder and Krebs, 1978, Kuppermann and Kasamatsu, 1984,…”
The impact of reinforcement contingencies on AD/HD: A review and theoretical appraisal
Luman, M., Oosterlaan, J., & Sergeant, J. A. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.11.001 · Cited by 541
Chronis-Tuscano, A., Degnan, K. A., Pine, D. S., Perez-Edgar, K., Henderson, H. A., Diaz, Y., Raggi, V. L., & Fox, N. A. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ae09df · Cited by 530
Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520 · cited 3×
“[PubMed: 8895456] Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER.”
Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509 · cited 1×
“Dynorphin may represent a second novel neuropeptide treatment given its role in anhedonic behaviors (Pliakas et al., 2001, Knoll and Carlezon, 2010).”
Teicher, M. H., Andersen, S. L., & Hostetter, J. C. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00109-q · Cited by 505
Self-citationPharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 2×
“The behavioral evidence is specific to enhanced 5-HT neurotransmission during a sensitive period of development and not alterations in norepinephrine levels (Hyttel, 1994, Ansorge et al., 2008, Popa et al., 2008).”
Direct and indirect pathways from the amygdala to the frontal-lobe in rhesus-monkeys
Porrino, L. J., Crane, A. M., & Goldman‐Rakic, P. S. (1981) · Journal of Comparative Neurology · doi:10.1002/cne.901980111 · Cited by 491
Cunningham, M. G., Bhattacharyya, S., & Benes, F. M. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10376 · Cited by 474
Specific GABA A Circuits for Visual Cortical Plasticity
Fagiolini, M., Fritschy, J.-M., Löw, K., Möhler, H., Rudolph, U., & Hensch, T. K. (2004) · Science · doi:10.1126/science.1091032 · Cited by 471
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry
Dalley, J. W., Mar, A. C., Economidou, D., & Robbins, T. W. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.021 · Cited by 467 · cited 1×
“In adult normal rats and non-human primates, elegant microinjection studies have determined that changes in the 5-HT1a and 5-HT2c receptors play a role in impulsivity within specific cortical and subcortical regions in adults (Dalley et al., 2008).”
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Dynamic mapping of normal human hippocampal development
Gogtay, N., Nugent, T. F., Herman, D. H., Ordonez, A., Greenstein, D., Hayashi, K. M., Clasen, L., Toga, A. W., Giedd, J. N., Rapoport, J. L., et al. (2006) · Hippocampus · doi:10.1002/hipo.20193 · Cited by 426
Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420 · cited 8×
“The when and where of BDNF and the antidepressant response.”
InfluentialRobinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359 · cited 1×
“In the single study in juvenile animals, 1 mg/kg atomoxetine reduced hyperactivity (Robinson et al., 2008).”
Cerebellar development and clinical outcome in attention deficit hyperactivity disorder
Mackie, S., Shaw, P., Lenroot, R., Pierson, R., Greenstein, D. K., Nugent, T. F., Sharp, W. S., Giedd, J. N., & Rapoport, J. L. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.4.647 · Cited by 333
Andersen, S. L., & Teicher, M. H. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.09.009 · Cited by 326
Self-citationErnst, M., Zametkin, A. J., Matochik, J. A., Jons, P. H., & Cohen, R. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05901.1998 · Cited by 320
Kuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · cited 1×
“Our discussion here will be limited to animal studies that used 3 mg/kg of MPH or less (Kuczenski and Segal, 2002) and not those studies designed to test hypotheses related to off-label recreational use.”
Barriers to detection, help-seeking, and service use for children with ADHD symptoms
Bussing, R., Zima, B. T., Gary, F. A., & Garvan, C. W. (2003) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02289806 · Cited by 303 · cited 1×
“Boys with ADHD are more likely to receive treatment and receive treatment earlier than girls with ADHD (Barbaresi et al., 2006, Bussing et al., 2003).”
Brenhouse, H. C., Sonntag, K. C., & Andersen, S. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5064-07.2008 · Cited by 287
Self-citationWindows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model
Adriani, W., & Laviola, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00005 · Cited by 267
Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07091465 · Cited by 263 · cited 7×
“Prepubertal treatment of ADHD with stimulants reduces the risk for SUD in some instances – a finding that is supported by both retrospective and prospective studies (Mannuzza et al., 2003, Mannuzza et al., 2008, Wilens et al., 2003).”
InfluentialPsychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder
Shaw, P., Sharp, W. S., Morrison, M., Eckstrand, K., Greenstein, D. K., Clasen, L. S., Evans, A. C., & Rapoport, J. L. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050781 · Cited by 261 · cited 2×
“stimulants are not associated with gross changes in structure (Shaw et al., 2009).”
Altered responsiveness to cocaine in rats exposed to methylphenidate during development
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259 · cited 5×
“…the prediction that MPH enhances sensitivity to stimulants later in life (Zakharova et al., 2009, Melnick and Dow-Edwards, 2001, Brenhouse et al., 2009), which is opposite to the effects in male rats at the same age of exposure (Andersen et al., 2002b) or clinical outcomes (Wilens et al., 2003).”
InfluentialSelf-citationMOLINA, B. S. G., FLORY, K., HINSHAW, S. P., GREINER, A. R., ARNOLD, L. E., SWANSON, J. M., HECHTMAN, L., JENSEN, P. S., VITIELLO, B., HOZA, B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180686d96 · Cited by 255 · cited 1×
“The enduring benefit of stimulant exposure on reduced SUD is especially applicable to ADHD individuals with comorbid conduct disorder (Mannuzza et al., 2008, Molina et al., 2007).”
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Figueiredo, H. F., Bruestle, A., Bodie, B., Dolgas, C. M., & Herman, J. P. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02932.x · Cited by 251
Common and Distinct Amygdala-Function Perturbations in Depressed vs Anxious Adolescents
Beesdo, K., Lau, J. Y. F., Guyer, A. E., McClure-Tone, E. B., Monk, C. S., Nelson, E. E., Fromm, S. J., Goldwin, M. A., Wittchen, H.-U., Leibenluft, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.545 · Cited by 250 · cited 1×
“Vulnerable populations may be identifiable with fMRI whereby individual, atypical patterns of fronto-limbic circuits may be an early indicator of cognitive and behavioral inflexibility (e.g., McClure-Tone, 2009, Beesdo et al., 2009).”
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Self-citationDo Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009) · Pediatrics · doi:10.1542/peds.2008-3347 · Cited by 246
Gordon, I., Zagoory‐Sharon, O., Schneiderman, I., Leckman, J. F., Weller, A., & Feldman, R. (2008) · Psychophysiology · doi:10.1111/j.1469-8986.2008.00649.x · Cited by 232 · cited 1×
“Recently, oxytocin was demonstrated to be strongly associated with low parental attachment, but with a high propensity for anxiety and depressive symptoms in young adults (Gordon et al., 2008).”
Leussis, M. P., & Andersen, S. L. (2008) · Synapse · doi:10.1002/syn.20462 · Cited by 220 · cited 3×
“In a study of adolescent depression produced by exposure to social stressors, we demonstrated a reversal of synaptic loss in the PFC by treatment with the NMDA antagonist MK-801 (Leussis and Andersen, 2008).”
Self-citationA three-country comparison of psychotropic medication prevalence in youth
Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C. (2008) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-2-26 · Cited by 201
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
Heal, D. J., Cheetham, S. C., & Smith, S. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.020 · Cited by 198 · cited 2×
“Three main classes of pharmacotherapy are used for the treatment of ADHD: methylphenidate (MPH), amphetamines, and atomoxetine (Heal et al., 2009).”
Bari, A., Eagle, D. M., Mar, A. C., Robinson, E. S. J., & Robbins, T. W. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1537-0 · Cited by 194
Nair, A., Vadodaria, K. C., Banerjee, S. B., Benekareddy, M., Dias, B. G., Duman, R. S., & Vaidya, V. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301276 · Cited by 189
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., Rush, A. J., Tao, R., & Rintelmann, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091453 · Cited by 188
Prevalence and patterns of antidepressant drug use during pregnancy
Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., de Jong-van den Berg, L., & Egberts, T. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0177-0 · Cited by 174 · cited 1×
“SSRIs are used to control maternal mood problems and are one of the most frequently prescribed classes of medications during pregnancy (Velves et al., 2006).”
Stimulants and the developing brain
Andersen, S. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.009 · Cited by 168 · cited 4×
“In summary, Figure 2 provides a working model of how sensitive periods interact with brain development to either produce an increase in behaviors or reduce behaviors, depending on the nature of the drug that is used (Andersen and Navalta, 2004,Andersen, 2005).”
InfluentialSelf-citationAngelucci, F., Aloe, L., Jiménez-Vasquez, P., & Mathé, A. A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003468 · Cited by 157
Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143366 · Cited by 147
Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging
Rapoport, J. L., & Gogtay, N. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301553 · Cited by 132 · cited 2×
“In this vein, we believe that information from normal animals may be misleading in terms of guiding clinical practice directly (Rapoport and Gogtay, 2008).”
Verney, C., Lebrand, C., & Gaspar, P. (2002) · The Anatomical Record · doi:10.1002/ar.10089 · Cited by 119 · cited 1×
“Serotonin—5-HT is involved in sculpting maturing circuitry and this process depends on 5-HT levels (Azmitia and Whitaker-Azmitia, 1991, Verney et al., 2002).”
A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study
Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.687 · Cited by 109 · cited 2×
“Moreover, MPH itself has a relatively high affinity to 5-HT1a and 5- HT2b receptors, which may expand its mechanism of action beyond the catecholamines (Markowitz et al., 2006).”
Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons
Brandon, C. L., Marinelli, M., & White, F. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00787-x · Cited by 107 · cited 1×
“Although the functional significance of MPH-induced BDNF changes are not well-understood, drug-induced changes within the genome (e.g. c-fos immunoreactivity) differ depending on the age of exposure (Penner et al., 2002, Brandon et al., 2003).”
Teicher, M. H., Samson, J. A., Polcari, A., & Andersen, S. L. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04235 · Cited by 100 · cited 5×
“In a cohort of exclusively female subjects exposed to childhood sexual abuse, but no other forms of abuse or trauma, depression onset in 62% of the subjects was delayed 9.2±3.6 years from the first episode of abuse (Teicher et al., 2009).”
InfluentialSelf-citationHeath, C. J., & Picciotto, M. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.020 · Cited by 99 · cited 1×
“Similarly, ADHD-like symptoms can be recapitulated in animals exposed to nicotine during development (Heath and Picciotto, 2009).”
Kim, B. N., Lee, J. S., Cho, S. C., & Lee, D. S. (2001) · Yonsei Medical Journal · doi:10.3349/ymj.2001.42.1.19 · Cited by 88
Mannuzza, S., Klein, R. G., & Moulton, J. L. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322572606 · Cited by 83
Neurodevelopmental effects of prenatal exposure to psychotropic medications
Gentile, S. (2010) · Depression and Anxiety · doi:10.1002/da.20706 · Cited by 76
Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test
Crowley, J. J., Brodkin, E. S., Blendy, J. A., Berrettini, W. H., & Lucki, I. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301065 · Cited by 61 · cited 2×
“Pharmacogenomics This rapidly evolving field may identify new targets, including four genes affected by antidepressants in adult animals (Crowley et al., 2006, Heurteaux et al., 2006, Svenningsson and Greengard, 2007, Tsankova et al., 2006).”
Berretta, S., Lange, N., Bhattacharyya, S., Sebro, R., Garces, J., & Benes, F. M. (2004) · Hippocampus · doi:10.1002/hipo.20002 · Cited by 61
Jezierski, G., Zehle, S., Bock, J., Braun, K., & Gruss, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04927.x · Cited by 41
Brenhouse, H. C., Dumais, K., & Andersen, S. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.063 · Cited by 38 · cited 1×
“For example, we recently found that atomoxetine decreases the time required for adolescent rats to extinguish cocaine-associated cues (Brenhouse et al., 2010), which typically is almost twice as long as adults (Brenhouse and Andersen, 2008).”
Self-citationJuvenile methylphenidate exposure and factors that influence incentive processing
Brenhouse, H. C., Napierata, L., Kussmaul, L., Leussis, M., & Andersen, S. L. (2009) · Developmental Neuroscience · doi:10.1159/000207498 · Cited by 24
Self-citation
Cited by
Experience and the developing prefrontal cortex
Kolb, B., Mychasiuk, R., Muhammad, A., Li, Y., Frost, D. O., & Gibb, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121251109 · Cited by 564
Sensitive periods of substance abuse: Early risk for the transition to dependence
Jordan, C. J., & Andersen, S. L. (2017) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2016.10.004 · Cited by 455
“…o c l a ( l ( e t s e o 4 a u dysregulation, Heightened startle/arousal ubcortical regions that persist in adulthood (Squeglia et al., 2009). rain regions that are influenced by drug exposure depend on heir state of maturation when drug exposure occurs (Andersen, 005; Andersen and Navalta, 2011).”
Self-citationInstitutional Care for Young Children: Review of Literature and Policy Implications
Dozier, M., Zeanah, C. H., Wallin, A. R., & Shauffer, C. (2012) · Social Issues and Policy Review · doi:10.1111/j.1751-2409.2011.01033.x · Cited by 198
Antidepressants and the adolescent brain
Cousins, L., & Goodyer, I. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573542 · Cited by 61
“It has been suggested that changes seen during a depressive episode in an adult brain are more likely to be reversible compared with those that might occur in the developing adolescent brain (Andersen and Navalta, 2011).”
Background
Metadata
- Authors
- Andersen, S. L., & Navalta, C. P.
- Venue
- Journal of Child Psychology and Psychiatry
- Publisher
- Wiley
- Published
- 2011-02-10
- Volume
- 52
- Issue
- 4
- Pages
- 476-503
- ISSN
- 0021-9630 (ISSN-L)
- 1469-7610
- OpenAlex
- W2143182818
- Cited by
- 38
- References
- 105
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.